ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

First-line nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients with advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 Chinese subgroup analysis 2-year follow-up

Shen, L.; Bai, Y.; Lin, X.; Li, W.; Wang, J.; Zhang, X.; Pan, H.; Bai, C.; Bai, L.; Cheng, Y.; Zhang, J.; Zhong, H.; Ba, Y.; Hu, W.; Xu, R.; Guo, W.; Qin, S.; Yang, N.; Lu, J.; Chanaga, C. Amaya; Soleymani, S.; Liu, T.复旦大学; 吉林大学; 青岛大学; 哈尔滨医科大学; 中山大学; 中国医学科学院北京协和医院; 1
2022-6DOI: 10.1016/j.annonc.2022.04.176
1被引4阅读
引用收藏
分享
相关
加载中…
  • First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis
    Liu, Tianshu; Bai, Yuxian; Lin, Xiaoyan; Li, Wei; Wang, Jufeng; Zhang, Xiaochun; Pan, Hongming; Bai, Chunmei; Bai, Li; Cheng, Ying; Zhang, Jingdong; Zhong, Haijun; Ba, Yi; Hu, Wenwei; Xu, Ruihua; Guo, Weijian; Qin, Shukui; Yang, Nong; Lu, Jianwei; Shitara, Kohei; Lei, Ming; Li, Mingshun; Bao, Nicole; Chen, Tian; Shen, Lin*International Journal of Cancer, 2023, 152(4): 749-760.被引 5
  • KEYNOTE-859 study of pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Outcomes in the protocol-specified PD-L1-selected populations
    Rha, Sun Young; Wyrwicz, Lucjan; Weber, Patricio Eduardo Yanez; Bai, Yuxian; Ryu, Min-Hee; Lee, Jeeyun; Rivera, Fernando; Alves, Gustavo Vasconcelos; Garrido, Marcelo; Shiu, Kai-Keen; Fernandez, Manuel Gonzalez; Li, Jin; Lowery, Maeve Aine; Cil, Timucin; Cruz, Felipe Melo; Qin, Shukui; Yin, Lina; Bordia, Sonal; Bhagia, Pooja; Oh, Do-YounAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.被引 4
  • Pembrolizumab (Pembro) or placebo (Pbo) plus chemotherapy (Chemo) for advanced HER2-negative gastric/gastroesophageal junction (G/GEJ) adenocarcinoma (KEYNOTE-859): Asia subgroup analysis
    Oh, D-Y.; Bai, Y.; Ryu, M. H.; Lee, J.; Li, J.; Luo, S.; Pan, H.; Qu, Y.; Lu, J.; Yang, L.; Yasui, H.; Yabusaki, H.; Yen, C. J.; Chan, W. W. L.; Yamaguchi, K.; Yeh, K-H.; Yin, L.; Bordia, S.; Bhagia, P.; Rha, S. Y.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 2023-12-01 To 2023-12-03.
查看全部 →

会议信息

论文集名
ANNALS OF ONCOLOGY
发表日期
2022-06
起止页码
S279-S279
DOI
10.1016/j.annonc.2022.04.176
资助标注
Bristol Myers Squibb
收录
SCIE

作者

  • S

    Shen, L. (第一作者)

    peking univ canc hosp & inst

  • B

    Bai, Y.

查看全部 22 位作者收起作者
  • L

    Lin, X.

    fujian med univ

  • L

    Li, W.

    1 · jilin univ

  • W

    Wang, J.

  • Z

    Zhang, X.

    qingdao univ

  • P

    Pan, H.

  • B

    Bai, C.

    peking union med coll hosp

  • B

    Bai, L.

    china pla gen hosp

  • C

    Cheng, Y.

  • Z

    Zhang, J.

    liaoning canc hosp & inst

  • Z

    Zhong, H.

    zhejiang canc hosp

  • B

    Ba, Y.

  • H

    Hu, W.

  • X

    Xu, R.

    sun yat sen univ

  • G

    Guo, W.

    fudan univ

  • Q

    Qin, S.

  • Y

    Yang, N.

    hunan canc hosp

  • L

    Lu, J.

  • C

    Chanaga, C. Amaya

  • S

    Soleymani, S.

  • L

    Liu, T.

    fudan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417